• Home
  • About Us
  • Mission
  • Stakeholders
• Chartered Value Exchange
• Health Plans
  • Quality Improvement Programs
  • Physician Quality Improvement Incentives
• Physician Alliance Overview
  • Educational Resources
  • 10 NCQA Hedis Measures Description
  • Evidence-Based Medicine
  • NYQA_HEDIS Specifications & Coding Tools
  • Frequently Asked Questions
• Quality Ambulatory Measures
  • Diabetes
  • Preventative Care
  • Appropriate Antibiotic Use
  • Heart Disease
  • American Heart Association Measures
• News
• Events
• Consumer Information
  • General Information
  • Diabetes
  • Heart Disease
  • Infection Control
  • Men's Issues
  • Women's Issues
• Project Documents
  • NYQA / WNYQMC Plan Reporting Elements Document
  • NYQA Hybrid Adjustment Methodology Document
• Links
• Contact Us

• HbA1C Testing

This measure is used to assess the percentage of members 18 through 75 years of age with diabetes (Type 1 and Type 2) who were continuously enrolled during the measurement year and who had a hemoglobin A1c (HbA1c) blood test.

• Lipid Measurement

This measure is used to assess the percentage of members 18 to 75 years with diabetes (Type 1 and Type 2) who were continuously enrolled during the measurement year and who had low-density lipoprotein cholesterol (LDL-C) test performed during the measurement year or prior to the measurement year.

• Eye Exam

This measure is used to assess the percentage of members 18 to 75 years of age with diabetes (Type 1 and 2) who were continuously enrolled during the measurement year and who had an eye exam (retinal) performed.

• Urine Protein Screening

This measure assesses the percentage of adult diabetes patients aged 18-75 years who received any test for levels of albumin (protein) in the urine, referred to as microalbuminuria.